STEPHANIE MURPHY: Open Payments
NPI 1811245434 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,008 in 118 payments from 19 companies in 2025. Trend: 2023 $2,224 · 2024 $1,843 · 2025 $2,008
Food & beverage: $1,987Education: $21
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $418 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $319 |
| Janssen Biotech, Inc. | 13 | $269 |
| Phathom Pharmaceuticals, Inc. | 17 | $201 |
| Gilead Sciences, Inc. | 7 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $152 |
| GENZYME CORPORATION | 4 | $89 |
| Sandoz Inc. | 4 | $79 |
| Madrigal Pharmaceuticals | 2 | $71 |
| Ferring Pharmaceuticals Inc. | 4 | $59 |
Products named: XIFAXAN, TREMFYA, VOQUEZNA, RINVOQ, ENTYVIO, CREON, DUPIXENT, LINZESS.
Industry payments across KY — which companies pay providers there.
